Related Experiment Video
Updated: Aug 8, 2026

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2
E N Tsitsikov1, D A Wright, R S Geha
1Division of Immunology, Children's Hospital, Department of Pediatrics Harvard Medical School, Boston, MA 02115, USA.
Insights
CD30 receptor ligation activates NF-kappaB and enhances HIV expression through TRAF-2 signaling in T lymphocytes. This study identifies TRAF2 as a key mediator in CD30-induced HIV transcription.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- CD30, a TNFR superfamily member, is expressed on immune cells.
- CD30 ligation is known to activate NF-kappaB and increase HIV expression.
Purpose of the Study:
- To investigate the role of TRAF proteins in CD30-mediated signaling.
- To elucidate the mechanism by which CD30 ligation affects HIV expression.
Main Methods:
- Studied TRAF1 and TRAF2 binding to the intracellular domain of CD30 (CD30IC).
- Utilized transient overexpression and dominant-negative mutants in KT3 T cell lines.
- Assessed NF-kappaB activation and HIV-1 long terminal repeat-driven transcription.
Main Results:
- TRAF1 and TRAF2 bind to CD30IC.
- TRAF2 overexpression, but not TRAF1, induced NF-kappaB activation and HIV-1 transcription.
- Dominant-negative TRAF mutants inhibited CD30-induced NF-kappaB activation and HIV-1 transcription.
Conclusions:
- CD30 signaling enhances HIV expression via TRAF-2-mediated NF-kappaB activation.
- TRAF2 is a critical component in the CD30-induced pathway for HIV transcription.
Abstract:
CD30 is a member of the tumor necrosis factor receptor (TNFR) superfamily expressed on activated T and B lymphocytes and natural killer cells. Ligation of CD30 was previously shown to induce NF-kappaB activation and HIV expression in chronically infected T lymphocytes. In this study, we report that two members of the TNFR-associated factor (TRAF) family of proteins, TRAF1 and TRAF2, independently bind to the intracellular domain of CD30 (CD30IC). Transient overexpression of TRAF2, but not TRAF1, induced NF-kappaB activation and HIV-1-long terminal repeat-driven transcription in the T cell line, KT3. Moreover, dominant negative mutants consisting of the TRAF domain of TRAF1 and TRAF2 inhibited CD30 induction of NF-kappaB activation and HIV-1 transcription. These results suggest that CD30 ligation may enhance the expression of HIV via TRAF-2-mediated activation of NF-kappaB.
More Related Videos
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
14:27CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites
Published on: November 14, 2018